A lottery like no other offers up a cutting-edge medicine — with lives on the line
COURTESY HILDA FODOR
Novartis is holding a lottery to obtain doses of Zolgensma, a gene therapy for infants with a former of spinal muscular atrophy.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario